Pharmaceutical Technology Europe-08-01-2012

Pharmaceutical Technology Europe

Germany has shifted from a market where the pharmaceutical industry could enjoy considerable pricing freedom to a sensitive market influenced by cost-containment policies.

Pharmaceutical Technology Europe

Most of the products affected by growing drug and ingredient shortages are cancer medications, anesthetics used for patients undergoing surgery, emergency medications and intravenous electrolytes.

Pharmaceutical Technology Europe
News

August 01, 2012

Pharmacovigilance rules enter into effect.

Cleaning validation provides assurance that the quantity of residual substances collected from equipment surfaces are within permissible limits, helping to ensure quality control and safety in pharmaceutical manufacturing facilities. Three different cleaning validation methods for measuring the carbon in residual samples of various pharmaceutical substances were compared.

Pharmaceutical Technology Europe

Enhancing bioavailability can be achieved through hot-melt extrusion (HME) or spray drying.

Pharmaceutical Technology Europe
Ingredients

August 01, 2012

Approaches centre on ways to optimise process conditions and operability.

Issue PDF
Pharmaceutical Technology Europe

August 01, 2012

Click the title above to open the Pharmaceutical Technology Europe August 2012 issue in an interactive PDF format.

Pharmaceutical Technology Europe
Interview

July 31, 2012

Dedong Wu, senior scientist at AstraZeneca, explains how nanoparticle engineering and crystal engineering can aid solubility.